Answer
Futibatinib irreversibly inhibits fibroblast growth factor receptors FGFR1, FGFR2, FGFR3 and FGFR4 by covalent binding.
Sources for this answer
- Lytgobi 4 mg film-coated tabletsTaiho Pharma Europe Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 3Document updated
Sources checked